Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Rev Esp Patol ; 55(4): 278-281, 2022.
Artigo em Espanhol | MEDLINE | ID: mdl-36154737

RESUMO

Intestinal (tailgut) cysts or retrorectal cystic hamartomas are rare benign lesions that are included in the category of developmental cystic lesions. Their origin is still uncertain, although several hypotheses have been proposed to explain their development. They are located mainly in the presacral (retrorectal) space and predominately affect middle-aged women (40-60 years). Taking into account location and histological characteristics, the main differential diagnoses include epidermoid cysts, duplication cysts and teratomas. Malignant transformation of these lesions is rare and preferentially into adenocarcinoma and neuroendocrine tumors. We present a case of an intestinal cyst associated with a well-differentiated neuroendocrine tumor (G1) in a 63-year-old woman.


Assuntos
Adenocarcinoma , Cistos , Hamartoma , Tumores Neuroendócrinos , Adenocarcinoma/complicações , Adenocarcinoma/patologia , Cistos/complicações , Cistos/patologia , Diagnóstico Diferencial , Feminino , Hamartoma/patologia , Humanos , Pessoa de Meia-Idade , Tumores Neuroendócrinos/complicações , Tumores Neuroendócrinos/diagnóstico
2.
Rev Esp Patol ; 55 Suppl 1: S64-S68, 2022 09.
Artigo em Espanhol | MEDLINE | ID: mdl-36075666

RESUMO

Syringocystadenoma papilliferum (SCAP), tubular adenoma (TA) and hydrocystoma (HC) are benign adnexal tumors. Recently it has been suggested that these lesions belong to the same morphological spectrum: Tubulopapillary cystic adenoma with apocrine differentiation (TPCAa). BRAF and K-Ras (KRAS) mutations have been described in SCAP and TA, but not in HC. Moreover, verrucous epithelial proliferations have been observed in TPCAa. We present a case of TPCAa with BRAF V600E mutation and BRAF VE1 immunohistochemical expression in the SCAP, AT, HC and verrucous hyperplasia components.


Assuntos
Adenoma , Neoplasias Gastrointestinais , Neoplasias das Glândulas Sudoríparas , Adenomas Tubulares de Glândulas Sudoríparas , Adenoma/genética , Adenoma/patologia , Humanos , Mutação , Proteínas Proto-Oncogênicas B-raf/genética , Neoplasias das Glândulas Sudoríparas/genética , Neoplasias das Glândulas Sudoríparas/patologia , Adenomas Tubulares de Glândulas Sudoríparas/genética , Adenomas Tubulares de Glândulas Sudoríparas/patologia
3.
Rev Esp Patol ; 54(3): 193-196, 2021.
Artigo em Espanhol | MEDLINE | ID: mdl-34175032

RESUMO

Hereditary leiomyomatosis (HL) is a rare autosomal dominant syndrome resulting from a mutation in the germline of the fumarate hydratase (FH) gene. Patients with this syndrome have an increased risk of cutaneous and uterine smooth muscle tumors as well as renal cancer. Renal carcinoma associated with hereditary leiomyomatosis (HLRCC) was recognized as a subtype of independent renal tumor in the 2016 WHO classification. We present a case of HLRCC occurring in a 39-year-old man with no family history or specific skin manifestations at the time of diagnosis.


Assuntos
Carcinoma de Células Renais/patologia , Neoplasias Renais/patologia , Leiomiomatose/patologia , Síndromes Neoplásicas Hereditárias/patologia , Neoplasias Cutâneas/patologia , Neoplasias Uterinas/patologia , Adulto , Carcinoma de Células Renais/química , Carcinoma de Células Renais/genética , Humanos , Neoplasias Renais/química , Neoplasias Renais/genética , Leiomiomatose/química , Leiomiomatose/genética , Masculino , Síndromes Neoplásicas Hereditárias/genética , Neoplasias Cutâneas/química , Neoplasias Cutâneas/genética , Neoplasias Uterinas/química , Neoplasias Uterinas/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA